On September 16, Stryker rose 3.16% in regular trading, trading at $290.08 per share with turnover of $138 million. The stock extended its recovery from the September 8 selloff, when shares dropped 7.5% to their lowest level since November 2023.

The Health Care Equipment sector showed broad-based strength, with Intuitive Surgical up 1.65%, Boston Scientific up 1.68%, Abbott up 0.97%, and Medtronic up 0.69%, while Baxter declined 1.71%. A recent industry report on surgical robots highlighted Stryker's dominant market position in joint replacement robotics through its MAKO system, which commands the overwhelming majority of installed capacity in the segment.

Fundamentally, Stryker posted strong Q2 results, with net sales of $6.589 billion, up 9.4% year-over-year, net profit surging 44.3% to $1.276 billion, and operating profit rising 49.1% to $1.659 billion, reflecting robust execution across its orthopaedics and MedSurg divisions.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)